MYCOBACTERIUM - ANVISA Registration 10339840494
Access comprehensive regulatory information for MYCOBACTERIUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840494 and manufactured by manufacturer not specified. The registration is held by DIASORIN LTDA with validity until Mar 11, 2029.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HAIN LIFESCIENCE GMBH, BECTON DICKINSON AND COMPANY (SPARKS), and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
10339840494
25351857451201808
01896764000170
Company Information
Dates and Status
Mar 11, 2019
11/03/2029
09/18/2025 19:00:01
MYCOBACTERIUM
Família LIAISON® QuantiFERON®-TB Gold Plus
Not specified
10339840550
Feb 05, 2024
MYCOBACTERIUM
Família LIAISON® QuantiFERON®-TB Gold Plus
DIASORIN ITALIA S.P.A.
10339840550
Feb 05, 2024
MYCOBACTERIUM
Família ichroma™ IGRA-TB
Not specified
10350840461
Aug 05, 2024
MYCOBACTERIUM
Família ichroma™ IGRA-TB
BODITECH MED INC.
10350840461
Aug 05, 2024
MYCOBACTERIUM
Família AutoLumo TB-IGRA Micropartículas (CLIA)
AUTOBIO DIAGNOSTICS CO., LTD
80102513450
Jun 16, 2025
MYCOBACTERIUM
RIDA® TB Tubes
R-BIOPHARM AG
82890930018
Sep 15, 2025
MYCOBACTERIUM
RIDA® TB Tubes
Not specified
82890930018
Sep 15, 2025
MYCOBACTERIUM
RIDA®QUICK TB
Not specified
82890930015
Jul 07, 2025
MYCOBACTERIUM
RIDA®QUICK TB
R-BIOPHARM AG
82890930015
Jul 07, 2025
MYCOBACTERIUM
RIDASCREEN® TB
R-BIOPHARM AG
82890930012
Jun 23, 2025